|Publication number||US7014643 B2|
|Application number||US 10/214,289|
|Publication date||Mar 21, 2006|
|Filing date||Aug 7, 2002|
|Priority date||Aug 7, 2001|
|Also published as||DE10138707A1, DE10138707C2, US20030036766|
|Publication number||10214289, 214289, US 7014643 B2, US 7014643B2, US-B2-7014643, US7014643 B2, US7014643B2|
|Inventors||Karl Engelhard, Hans-Peter Hollenbach|
|Original Assignee||Siemens Aktiengesellschaft|
|Export Citation||BiBTeX, EndNote, RefMan|
|Patent Citations (10), Referenced by (1), Classifications (16), Legal Events (4)|
|External Links: USPTO, USPTO Assignment, Espacenet|
1. Field of the Invention
The present invention is directed to an apparatus for conducting an endorectal prostrate biopsy procedure, and in particular to a device for such a procedure conducted using magnetic resonance (MR) supervision.
2. Description of the Prior Art
Pathological changes of the prostate are a very common disease not only in advanced age. An increasing number of prostate patients require a prostate biopsy since, left untreated, the prostate carcinoma metastasizes into the adjoining lymph nodes and bones and becomes incurable beyond a certain extent of the disease. In addition to supplying the PSA value (prostate-specific antigen) that is determined from the blood specimen, a biopsy supplies additional information that is absolutely necessary for evaluating benefits and risks of a surgery.
Heretofore, such a biopsy has been implemented substantially “blind,” under ultrasound supervision or as a multi-biopsy with up to 24 specimens. Frequently, however, pathological changes or the corresponding areas are visible only in an MR image.
A stereotactic attachment for a nuclear magnetic resonance tomography apparatus is proposed in German PS 43 25 206, but has not proven to be an improvement for endorectal prostate biopsy. German PS 43 25 206 describes an arrangement of apertured plates that is envisioned for a breast cancer biopsy, wherein the apertured plates can be moved toward and away from one another. The breast is compressed between the two plates, and the location at which a suspicious node is located is detected with appropriate imaging methods. Subsequently, a needle is applied exactly above this location and is pushed vertically downward. There is no mention of any sort of guide mechanism movable in space with which target region can be designationally approached, as is the case in prostate biopsy. The arrangement disclosed in German PS 43 25 206 accordingly, is completely unsuited for an endorectal prostate biopsy.
The same is true of an instrument guidance device for brain surgeries as proposed in U.S. Pat. No. 4,809,694. The guidance device disclosed therein allows an instrument to be swiveled in all possible directions on the basis of a ball bearing. This patent, however, does not provide any teachings as to how a specific, suspicious location is to be targeted with such an instrument in a prostate biopsy.
An object of the present invention is to provide a device for an MR-guided endorectal prostate biopsy procedure that enables an exact targeting of a suspicious target area for the removal of a biopsy specimen in a simple way.
This object is inventively achieved in a biopsy guidance device connected to an MR system that is secured to the patient support table, so as to be alignable via the MR system for alignment and guidance of the biopsy needle into a preselectable target area, and wherein the biopsy guidance device contains MR-imaging markers and is provided with a trajectory setting mechanism with which the selected and calculated trajectory can be set.
Image datasets in 2D and/or 3D of the patient can be registered wherein the physician determines the paracentesis point and target point of the biopsy. The optimum 3D biopsy trajectory and the paracentesis depth can be calculated from these points.
The biopsy guidance device can be either manually adjustable or motor-adjustable using a calculating unit coupled to the MR system.
After the alignment of the biopsy device has ensued in this way, a check of the trajectory ensues by MR imaging along the trajectory in two planes.
The technique made available with the inventive device allows a high-quality biopsy given simultaneously low cost outlay and low stress and negligible risk for the patient.
In a first embodiment of the invention, the biopsy guidance device contains a freely rotatably seated sphere having a guide channel for the biopsy needle. The sphere can have graduated circles around its poles and equator with degree divisions for setting the guidance trajectory on the basis of the measured MR image datasets.
It has proven especially expedient in an embodiment of the invention to provide trajectory monitoring cavities that can be filled with water and that proceed parallel to the guidance channel, these being visible in the MR image. During the implementation of the intervention, the trajectory thus can be tracked at any time under MR-imaging supervision.
In a second embodiment of the invention, the biopsy guidance device has a guidance block with a number of guidance channels proceeding through the block that are inclined relative to one another and correspond to possible biopsy trajectories.
The guidance channels can be numbered, and the best-suited channel is selected after the production of the MR image datasets.
In a further embodiment of the invention the biopsy guidance device contains spaced apertured grid plates for prescribing the possible biopsy trajectories. The combinations of the multiple holes in one of the plates with one of the multiple holes of the other plate yields a large number of possible trajectories along which the biopsy needle can be guided.
Fundamentally, an endorectal coil with a prostate biopsy attachment can be provided for the implementation of a biopsy procedure with the inventive device. Due to the greater freedom and the more versatile guidance possibilities, however, it has proven especially expedient to separate the biopsy device from the endorectal coil and to provide the biopsy needle with an inflatable rubber cuff or the like in the region of the needle tip for guidance thereof. The needle tip preferably is fashioned as a snap tip with an adjustable extended length. After being introduced, this simulates the endorectal coil pressed against the prostate in the prior image registration and causes to a displacement of the prostate as in the preceding fine structure exposure obtained with the endorectal coil.
As shown in
If a carcinoma is not detected, then the examination is ended. If a suspected carcinoma can be recognized in the images, then a decision must be made whether a biopsy is additionally needed. If a biopsy is not necessary, the examination can be ended. Given the need for a biopsy, the location to be biopsied, i.e. the target point, is marked in the MR image and the coordinates are thus defined. Subsequently, the biopsy device (
A sphere 2 having bores 3 and 4 lying opposite one another for a needle guide 5, for example a tube, is seated on a mount 1 so as to be rotatable in all directions, serves for guiding the biopsy needle under MR supervision in the exemplary embodiment according to
As needed, the needle guide 5 can have an articulation with the internally displaceable biopsy needle between the tip 6 and the inflatable rubber ball 7 in order to also be able to implement a targeting with the assistance of the inventive device in the case of an unfavorably placed carcinoma.
The invention is not limited to the illustrated exemplary embodiments. In particular, it would thus also be possible—and this is true for all embodiments of the biopsy guidance device but preferably for those with the freely rotatable sphere 2 according to FIGS. 2 and 3—to attach elongated cavities parallel to the guidance channel that can be filled with water and that are thus visible in the MR image. One such MR visible marker 18 is shown in
Although modifications and changes may be suggested by those skilled in the art, it is the intention of the inventors to embody within the patent warranted hereon all changes and modifications as reasonably and properly come within the scope of their contribution to the art.
|Cited Patent||Filing date||Publication date||Applicant||Title|
|US4809694 *||May 19, 1987||Mar 7, 1989||Ferrara Vincent L||Biopsy guide|
|US5678549||Jul 29, 1993||Oct 21, 1997||Siemens Aktiengesellschaft||Stereotactic auxiliary attachment for a nuclear magnetic resonance tomography apparatus|
|US5787886 *||Apr 10, 1995||Aug 4, 1998||Compass International Incorporated||Magnetic field digitizer for stereotatic surgery|
|US5947964 *||Jul 3, 1997||Sep 7, 1999||Neothermia Corporation||Methods and apparatus for therapeutic cauterization of predetermined volumes of biological tissue|
|US6119032 *||Dec 31, 1997||Sep 12, 2000||U.S. Philips Corporation||Method and system for positioning an invasive device by magnetic resonance (MR) imaging of an MR visible device|
|US6149592 *||Nov 26, 1997||Nov 21, 2000||Picker International, Inc.||Integrated fluoroscopic projection image data, volumetric image data, and surgical device position data|
|US6195577 *||Jan 28, 1999||Feb 27, 2001||Regents Of The University Of Minnesota||Method and apparatus for positioning a device in a body|
|US6470204 *||Jul 3, 2000||Oct 22, 2002||Egidijus Edward Uzgiris||Intracavity probe for MR image guided biopsy and delivery of therapy|
|US6493574 *||Sep 28, 2000||Dec 10, 2002||Koninklijke Philips Electronics, N.V.||Calibration phantom and recognition algorithm for automatic coordinate transformation in diagnostic imaging|
|US6574497 *||Dec 22, 2000||Jun 3, 2003||Advanced Cardiovascular Systems, Inc.||MRI medical device markers utilizing fluorine-19|
|Citing Patent||Filing date||Publication date||Applicant||Title|
|US7477054 *||Apr 22, 2005||Jan 13, 2009||Koninklijke Philips Electronics N.V.||Magnetic resonance imaging at several RF frequencies|
|U.S. Classification||606/130, 600/417, 600/414, 600/410|
|International Classification||A61B17/00, A61B10/00, A61B19/00, A61B10/02, A61B5/055, G01R33/28|
|Cooperative Classification||A61B19/201, A61B10/0241, A61B2017/00274, A61B2018/00547, A61B2019/5236|
|Oct 30, 2002||AS||Assignment|
Owner name: SIEMENS AKTIENGESELLSCHAFT, GERMANY
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:ENGELHARD, KARL;HOLLENBACH, HANS-PETER;REEL/FRAME:013443/0139
Effective date: 20020814
|Oct 26, 2009||REMI||Maintenance fee reminder mailed|
|Mar 21, 2010||LAPS||Lapse for failure to pay maintenance fees|
|May 11, 2010||FP||Expired due to failure to pay maintenance fee|
Effective date: 20100321